Apocrine adenocarcinoma of the head and neck district: Our experience with two cases.

Autor: Ferragina F; Department of Experimental and Clinical Medicine, Unit of Maxillofacial Surgery, 'Magna Graecia' University, Viale Europa, 88100 Catanzaro, Italy. Electronic address: francesco.ferragina92@gmail.com., Barca I; Department of Experimental and Clinical Medicine, Unit of Maxillofacial Surgery, 'Magna Graecia' University, Viale Europa, 88100 Catanzaro, Italy., Sorrentino A; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Unit of Maxillofacial Surgery, University Hospital of Naples 'Federico II', 80131 Napoli, Italy., Sottile AR; Department of Experimental and Clinical Medicine, Unit of Maxillofacial Surgery, 'Magna Graecia' University, Viale Europa, 88100 Catanzaro, Italy., Cristofaro MG; Department of Experimental and Clinical Medicine, Unit of Maxillofacial Surgery, 'Magna Graecia' University, Viale Europa, 88100 Catanzaro, Italy.
Jazyk: angličtina
Zdroj: International journal of surgery case reports [Int J Surg Case Rep] 2023 Nov; Vol. 112, pp. 109017. Date of Electronic Publication: 2023 Nov 04.
DOI: 10.1016/j.ijscr.2023.109017
Abstrakt: Introduction: Apocrine adenocarcinoma (AA) is a rare gland cancer that appears in the elderly, especially males. Surgery is considered the first option for the management of this tumor.
Case Presentation: We report two cases of AA that occurred at our Unit of Maxillofacial Surgery. Precisely a case of a woman with AA with a usual presence at the eyelid level and a case of a man with AA with an unusual presence at the neck level.
Discussion: This cancer generally arises in some specific areas of the body that present high concentrations of apocrine glands (such as in Case No.2). But it can also occur in less typical areas, such as the neck (such as in Case No.1).
Conclusion: We discuss the surgical management of our cases: both based on our experience and literature data, we recommend extensive surgical excision.
Competing Interests: Conflict of interest statement The authors declare that they have no conflict of interest.
(Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE